2nd Next Generation RNA Therapeutics Summit
Evvnt Promotion / evvnt
16.05.2023 - 18.05.2023 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
8:00 am - 5:10 pm
Temi della conferenza
The 2nd Next Generation RNA Therapeutics Summit returns as the first and only industry-dedicated forum solely focused on next generation RNA therapeutics and vaccines that are more targeted, and efficacious, with reduced off targets than first generation RNA therapies to accelerate their therapeutic and commercial potential.
Expect exclusive data from KOLs on the most recent developments in circRNAs, saRNAs, eRNAs and tRNAs therapies.
The 2nd Next Generation RNA Therapeutics Summit returns as the first and only industry-dedicated forum solely focused on next generation RNA therapeutics and vaccines that are more targeted, and efficacious, with reduced off targets than first generation RNA therapies to accelerate their therapeutic and commercial potential.
Expect exclusive data from KOLs on the most recent developments in circRNAs, saRNAs, eRNAs and tRNAs therapies.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/1477463-3?pid=4832
Speakers: Alex Wesselhoeft, Founder, Director of Molecular Biology, Orna Therapeutics, Anna Senczuk, Process Development Director and mRNA CMC Lead, Seqirus Inc., and more.
URL:
Brochure: https://go.evvnt.com/1477463-3?pid=4832
Speakers: Alex Wesselhoeft, Founder, Director of Molecular Biology, Orna Therapeutics, Anna Senczuk, Process Development Director and mRNA CMC Lead, Seqirus Inc., and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/1477463-2?pid=4832
Mr. Hanson Wade
Oncologia
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
